What’s more, it has also been revealed that IL-6/AKT signal is inappropriately activated in several malignancies, including pancreatic cancer and gastric cancer, and its activation can enhance tumor development and resistance to some chemotherapeutic medicines [35]. This evidence concerns the gene IL6 and pancreatic neoplasm.